Published February 2019
| Version v1
Journal article
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526)
Creators
- 1. BC Cancer Agency and University of British Columbia, Kelowna, British Columbia (Canada)
- 2. NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia (United States)
- 3. Mayo Clinic, Rochester (United States)
- 4. Jefferson University, Philadelphia (United States)
- 5. Cedars-Sinai Medical Center, Los Angeles (United States)
Description
Only retrospective data are available for low-dose-rate (LDR) salvage prostate brachytherapy for local recurrence after external beam radiation therapy (EBRT). The primary objective of this prospective phase 2 trial (NCT00450411) was to evaluate late gastrointestinal and genitourinary adverse events (AEs) after salvage LDR brachytherapy.
Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2018.09.039;
- PII
- S0360301618338306;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 103
- Journal Issue
- 2
- Journal Page Range
- p. 335-343
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55057276
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- AUGER ELECTRON SPECTROSCOPY; BRACHYTHERAPY; DOSE RATES; EXTERNAL BEAM RADIATION THERAPY; NEOPLASMS; PROSTATE
- Descriptors DEC
- BODY; DISEASES; ELECTRON SPECTROSCOPY; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RADIOTHERAPY; SPECTROSCOPY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2018 Elsevier Inc. All rights reserved.